Community participation needed for “Bras for a Cause”

Translate to Spanish or other 102 languages!

Photo Used for Illustration Purposes. Photo by drazenphoto
- Advertisement -

Every October, DHR Health employees tap into their creativity to participate in the hospital’s annual “Bras for a Cause” fundraiser. This event supports underserved cancer patients throughout the Rio Grande Valley by providing vital resources such as transportation assistance, financial aid, and oncology wigs through the Renaissance Cancer Foundation.

This year, nearly 30 decorated bras were submitted by employees from various departments, showcasing their enthusiasm for raising awareness about breast cancer screenings and mammograms.

“We hold this contest every year as a fun and engaging way for our employees to help promote breast cancer awareness,” said Evelyn Saenz, Executive Director of the Renaissance Cancer Foundation. “We’re always so impressed by the many creative entries we receive.”

- Advertisement -

Community members are encouraged to visit www.dhrhealth.com/brasforacause to view photos of the bra entries and cast their votes by making donations. The bras with the highest donation totals will be declared winners of the fundraiser. Voting is open to the community until October 20, 2024.

All donations to the Renaissance Cancer Foundation are tax-deductible and directly support local cancer patients facing financial challenges during their treatment. For more information about the Renaissance Cancer Foundation or how to get involved, please contact Executive Director Evelyn Saenz at ev.saenz@dhr-rgv.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Bariatric Alumni Mark Health Journeys in Transformation Fashion Show

Obesity continues to be a significant public health challenge across the United States, including the Rio Grande Valley.

TMA Honors Georgetown Pediatrician for a Career of Distinguished Service 

The Texas Medical Association (TMA) has honored Georgetown pediatrician John W. Hellerstedt, MD, with the 2026 TMA Distinguished Service Award in recognition of his 45 years of exemplary service to patients, public health, and organized medicine.   

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.
- Advertisement -